… Immunohistochemical staining of hepatocellular carcinoma sections with the anti-glypican-3
(GPC3) 1G12 monoclonal antibody. (a) Low power picture of a GPC3-positive multinodular …

… However,the differential diagnosis between alpha fetoprotein(AFP) negative HCC and
cirrhotic nodules is still difficult. Objectives: To evaluate the diagnostic value of glypican-3(GPC3) …

Backgrounds Glypican-3(GPC3) has been reported as one of the most promising serum
markers for hepatocellular carcinoma (HCC), while several studies have conflicting results for …

… Aims: Glypican 3 (GPC3) has been reported to be overexpressed in yolk sac tumour (YST),
but the sensitivity has not been compared with α-fetoprotein (AFP). YST can form numerous …

… Aims Glypican 3 (GPC3) is a cell surface heparan sulphate proteoglycan expressed
specifically in the fetal liver and malignant neoplasms of hepatocyte lineage. The aim was to …

Methods We enrolled 157 consecutive patients with newly diagnosed HCC and 156 patients
with liver cirrhosis (LC) as the control group. GPC3 plasma levels were measured using two …

… Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a …
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non…

… Glypican-3 mRNA was intensively detected in 30 of 41 AFP-negative HCC (73.17%). In contrast,
Glypican3 … Serum alphafetoprotein in the early stage of human hepatocellular carcinoma…

… Glypican 3 was expressed in 11% of GC in the present study, of which 5% were diffuse-type
GPC3-GC and 6% were focal-type GPC3-GC. Diffuse-type GPC3-GC showed significantly …

… glypican 3 in germ cell tumors and other neoplasms in addition to hepatocellular carcinoma.
In conclusion, glypican 3 … -characterized α-fetoprotein (AFP). In this article, the expression of …